Lisa Heinrichs
Overview
Explore the profile of Lisa Heinrichs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jordens M, Oswald H, Heinrichs L, Gassmann N, Wittig L, Luedde T, et al.
World J Surg Oncol
. 2025 Jan;
23(1):9.
PMID: 39762956
Background: Hepatocellular Carcinoma (HCC) and cholangiocellular adenocarcinoma (CCA) are the most common primary liver tumors representing a major global health burden. In early disease stages, tumor resection may provide long-term...
2.
Bone mineral density as a prognostic marker in patients with biliary tract cancer undergoing surgery
Heinrichs L, Fluegen G, Loosen S, Loberg C, Wittig L, Quaas A, et al.
BJC Rep
. 2024 Sep;
2(1):72.
PMID: 39323978
Background: Biliary tract cancer (BTC) is one of the most aggressive malignancies and surgery represents the only curative treatment approach. However, even in patients with complete tumor resection 5-year survival...
3.
Scholer D, Loosen S, Wirtz T, Brozat J, Dos Santos Ferreira Grani L, Luedde T, et al.
Front Cardiovasc Med
. 2023 Jun;
10:1163525.
PMID: 37293281
Background: Heart disease is of worldwide importance due to high morbidity and mortality. Extracellular vesicle (EV) concentration and size represent novel diagnostic and prognostic biomarkers, e.g. in patients with liver...
4.
Jordens M, Wittig L, Loberg C, Heinrichs L, Keitel V, Schulze-Hagen M, et al.
Biomedicines
. 2022 Jul;
10(7).
PMID: 35884968
Background: Cholangiocellular adenocarcinoma (CCA) is a rare and aggressive malignancy originating from the bile ducts. Its general prognosis is poor as therapeutic options are limited. Many patients present with advanced...
5.
Jordens M, Heinrichs L, Loosen S, Wittig L, Keitel V, Scholer D, et al.
Cancers (Basel)
. 2021 Nov;
13(21).
PMID: 34771524
Introduction: Surgery represents the only curative treatment option for patients with cholangiocarcinoma. However, complete tumor resection requires extensive surgery in many patients, and it is still debated which patients represent...
6.
Jordens M, Wittig L, Heinrichs L, Keitel V, Schulze-Hagen M, Antoch G, et al.
J Clin Med
. 2021 Oct;
10(19).
PMID: 34640358
Background: Cholangiocarcinoma (CCA) represents the second most common primary liver cancer and is characterized by a very poor outcome, but reliable prognostic markers are largely missing. Sarcopenia, the progressive loss...